Production (Stage)
D
Elevation Oncology, Inc. ELEV
$0.3817 $0.00150.40% NASDAQ
Recommendation
Prev Close
$0.3817
Volume
801,879
Avg Vol (90D)
1,558,300
Market Cap
$22.62M
Dividend & Yield
--
52-Week Range
$0.221 - $3.36
P/E (TTM)
--
EPS (TTM)
-$0.8118
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRKN, ELEV, STR, VIGL on Behalf of Shareholders
6/13/2025 - Globe Newswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates KNW, ELEV, CRKN on Behalf of Shareholders
6/12/2025 - PR Newswire
ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & ...
6/10/2025 - GuruFocus
ELEVATION ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Elevation Oncology, Inc. - ELEV
6/10/2025 - Business Wire
Elevation Oncology (ELEV) Receives Analyst Rating Update ELEV Stock News
6/10/2025 - GuruFocus
Elevation Oncology (ELEV) Receives Downgrade from HC Wainwright & Co. ELEV Stock News
6/10/2025 - GuruFocus
Elevation Oncology (ELEV) Downgraded by H.C. Wainwright Amid Merger Plans ELEV Stock News
6/10/2025 - GuruFocus
Elevation Oncology downgraded to Neutral from Buy at H.C. Wainwright
6/10/2025 - TipRanks Financial Blog
Elevation Oncology just downgraded at H.C. Wainwright, here's why
6/10/2025 - The Fly
Elevation Oncology (ELEV) Downgraded Following Acquisition News ELEV Stock News
6/9/2025 - GuruFocus
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FLS, KNW, ELEV, CRKN on Behalf of Shareholders
6/9/2025 - PR Newswire
Elevation Oncology (ELEV) Downgraded by William Blair ELEV Stock News
6/9/2025 - GuruFocus
Elevation Oncology just downgraded at TD Cowen, here's why
6/9/2025 - The Fly
ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. ...
6/9/2025 - GuruFocus
ELEV Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Elevation Oncology, Inc. Is Fair to Shareholders
6/9/2025 - Business Wire
Elevation Oncology (ELEV) Downgraded by William Blair Following Acquisition Announcement ELEV ...
6/9/2025 - GuruFocus
Elevation Oncology downgraded to Market Perform from Outperform at William Blair
6/9/2025 - TipRanks Financial Blog
Elevation Oncology just downgraded at William Blair, here's why
6/9/2025 - The Fly
Elevation Oncology (ELEV) was downgraded to a Hold Rating at William Blair
6/9/2025 - TipRanks Financial Blog
Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0. ...
6/9/2025 - GuruFocus
Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0. ...
6/9/2025 - GuruFocus
Elevation Oncology (ELEV) to be Acquired by Concentra Biosciences ELEV Stock News
6/9/2025 - GuruFocus
Elevation Oncology Enters into Agreement to Be Acquired by Concentra Biosciences for $0.36 in Cash per Share Plus a Contingent Value Right
6/9/2025 - PR Newswire
embattled elevation becomes latest biotech accept concentra buyout
6/9/2025 - FierceBiotech.com - Biotech
Elevation Oncology Reports Q1 2025 Financial Results
5/17/2025 - TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
-$45.66M
EBIT (TTM)
-$45.68M
Net Income (TTM)
-$47.99M
Balance Sheet
Total Assets (Q)
$82.22M
Total Debt (Q)
$31.25M
Total Liabilities (Q)
$35.49M
Book Value Per Share (Q)
$0.7891
Cash Flow
Cash from Operations (TTM)
-$39.50M
Cash from Investing (TTM)
-$5.31M
Cash from Financing (TTM)
$14.67M
Net Change in Cash (TTM)
-$30.14M
Filings
Filing Date
Thursday, May 15, 2025
Period Date
Monday, March 31, 2025
Next Filing
Week of Aug 4 and 8 (est)
Price History
Loading...
Beta
2.29
7-Day Total Return
25.11%
30-Day Total Return
9.06%
60-Day Total Return
37.30%
90-Day Total Return
-43.09%
Year to Date Total Return
-35.86%
1-Year Total Return
-88.18%
2-Year Total Return
-75.05%
3-Year Total Return
-72.74%
5-Year Total Return
--
52-week Low
Apr 09, 2025 - $0.221
52-week High
Jun 14, 2024 - $3.36
Valuation
Market Cap
$22.62M - Nano Cap
Enterprise Value
-$26.79M
Price/Sales (TTM)
--
Price/Book (Q)
0.48
Dividends and Shares
Shares Outstanding
59.17M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
elevationoncology.com
Phone Number
716 371 1125
Address
101 Federal Street
Boston, MA 02110
Country
United States
Year Founded
2019
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Elevation Oncology, Inc., an oncology company, focuses on the discovery and development of cancer therapies to treat patients across a range of solid tumors with significant unmet medical needs... more
NASDAQ 06/13/2025 4:00PM Eastern Quotes delayed